The current study examines sex differences in 183 male and 141 female patie
nts presenting for care of HIV disease at an inner city hospital infectious
disease clinic. Females (43%) were found to be less likely to have a histo
ry of illicit drug use (relative risk = .77, p < .01) and more likely to ha
ve become infected heterosexually (relative risk = 2.38, p < .01). However,
a significant number of women reported both intravenous drug use (IVDU) an
d heterosexual exposure to an IVDU partner which complicates the analysis o
f the risk factors. Women sought testing because they knew that their sexua
l partners were HIV-positive (relative risk = 2.88, p < .01) Median CD4 cou
nts at entry were significantly different (females = 340, males = 246; p <
.01). Women were less likely to contract tuberculosis, the only infection w
hich presented with a sex difference (relative risk = .38, p < .01) and to
have previously had an AIDS defining infection (relative risk = .37, p < .0
1). Women took longer to progress to AIDS (42 vs. 19 months; p < .05). Surv
ival of patients with AIDS was 51 months for females and 54 for males (p >
0.9). It did appear that the effect of a lower CD4 cell count on risk for d
eath was magnified in patients who acquired their disease through heterosex
ual transmission. Women presented with higher CD4 counts, were more aware o
f their risk factors and fared better, with respect to progression to AIDS,
than the men. The study underscored the impact of heterosexual transmissio
n of the virus in women as well as the affect of this risk factor on diseas
e progression. Hopefully, this information will initiate further studies on
sex differences which will guide interventions and policy development.